Sluggish Myra

The story

Myra slows down for years and everyone calls it aging. Then a cold snap and a missed month of levothyroxine drop her into a sleep no one can wake her from.

Myra Higgins spent forty years as an archivist at the county records office, methodically filing birth certificates and deeds with quiet precision. Neighbors knew her as a deliberate, soft-spoken woman who moved with unhurried grace, but over recent months, deliberate turned into profoundly inert. Her friends nicknamed her Sluggish Myra, assuming her creeping exhaustion and muffled speech were simply normal manifestations of growing older. In reality, her moniker mirrored a catastrophic endocrine deceleration known as myxedema coma. Myra's cellular metabolic rate had plummeted toward an absolute standstill because her thyroid gland had ceased producing the essential hormones that regulate cellular energy. Every fundamental system in her body, from cerebral neurotransmission to cardiac pacemaking, ground down to an agonizing crawl beneath a thickening layer of mucopolysaccharide tissue infiltration.

The crisis gathered momentum in late December when fixed-income finances forced Myra to stop refilling her daily levothyroxine prescription. Compounding the missing medication, a brutal January polar vortex infiltrated her drafty, poorly heated apartment, placing immense thermal stress on her vulnerable frame. Classic warnings had emerged weeks earlier, yet everyone overlooked them. Her daughter noticed Myra's face had grown strangely bloated with nonpitting periorbital edema, her hairline was visibly thinning, and her voice sounded coarse and gravelly on the phone. Myra layered heavy wool sweaters indoors, cursed the unrelenting constipation, and began sleeping eighteen hours a day while still gaining weight. Stripped of synthetic hormone support and battling relentless ambient freezing temperatures, Myra's baseline chronic hypothyroidism quietly crossed a perilous threshold into decompensated, life-threatening metabolic failure.

When Myra failed to answer her door for two days, her daughter entered to find her completely unresponsive in bed, barely breathing and ice-cold to the touch. In the emergency department, her core temperature registered at a profound 33.9°C without a single shiver, as her depleted cells lacked the metabolic capacity to generate heat. Her cardiac monitor revealed severe bradycardia with a heart rate of 44 beats per minute, paired with a blood pressure of 82/50 mmHg. Respirations were critically depressed at 8 shallow breaths per minute. Serum chemistry confirmed severe hyponatremia at 122 mEq/L and a blood glucose of 58 mg/dL. Her arterial blood gas exposed acute respiratory acidosis with hypercapnia, driven by hypoventilation, while thyroid panels showed a massively elevated TSH alongside an undetectable free T4 level.

The emergency nurse immediately initiated priority interventions, beginning with endotracheal intubation and mechanical ventilation to secure Myra's failing airway and blow off retained carbon dioxide. After drawing baseline cortisol, the nurse administered intravenous hydrocortisone before giving intravenous levothyroxine, ensuring adrenal insufficiency was treated prior to accelerating metabolic demand. Instead of utilizing active external warming devices, the team placed standard cotton blankets and warmed the ambient room, as active heating is strictly contraindicated because sudden peripheral vasodilation causes profound hypotension and cardiovascular collapse. Intravenous fluids were infused cautiously to gradually correct hyponatremia without precipitating fluid overload. Continuous telemetry monitored for lethal arrhythmias while serial blood gases tracked ventilation, allowing Myra's cellular machinery to gently restart under vigilant hemodynamic and metabolic stabilization.